Ahead of SPAC merger, Exascale Labs locks in $71.4M GPU compute deal with Dimension AI
BCAR is trading near its 52-week low of $9.88 (4.9% above the low).
Summary
Exascale Labs, set to merge with BCAR in a $500M SPAC deal, announced a $71.4M, three-year GPU compute contract with Dimension AI, strengthening its commercial pipeline ahead of the shareholder vote.
Key Events · M&A and Partnerships · BCAR
-
$71.4M Compute Deal Signed
Exascale Labs entered into a three-year Compute Service Agreement with Dimension AI to procure approximately US$71.4 million of dedicated GPU compute capacity, expanding its GPU-as-a-Service platform.
-
Revenue Anchor for Merger
The contract provides a significant, multi-year revenue stream that supports the valuation of the pending $500 million SPAC merger with BCAR, addressing prior going-concern concerns.
-
Merger Vote Approaching
The definitive proxy statement for the business combination was mailed to BCAR shareholders on July 7, 2026, with the shareholder vote expected in the coming weeks.
-
Stock Near 52-Week Low
BCAR shares trade at $10.36, near the 52-week low of $9.88, reflecting market skepticism about the merger; this deal may help bolster investor confidence.
Analysis · BCAR · Technology
Exascale Labs, the target in a pending $500 million SPAC merger with D. Boral ARC Acquisition I Corp. (BCAR), has announced a three-year, $71.4 million compute services agreement with Dimension AI. The deal secures dedicated GPU capacity for Exascale's GPU-as-a-Service platform, validating demand for its AI infrastructure offering. This contract provides a tangible revenue anchor for the combined company, which has faced going-concern warnings and needs to demonstrate commercial traction to support the merger's valuation. The announcement comes as BCAR shares trade near 52-week lows, and the merger proxy has been mailed to shareholders for an upcoming vote.
At the time of this filing, BCAR was trading at $10.36 on NASDAQ in the Technology sector, with a market capitalization of approximately $420.2M. The 52-week trading range was $9.88 to $11.17. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.